A randomized, vehicle-controlled clinical trial of a synthetic TRPM8 agonist (Cryosim-1) gel for itch - 15/02/21
Drs Jung and Kim contributed equally to this article. |
|
Funding sources: Supported by grants from Dong Wha Pharmaceutical and the National Research Foundation of Korea (2017R1A2B4006252); Korea Centers for Disease Control and Prevention (2020-ER6714-00); and the Korea Healthcare Technology Research and Development Project, funded by the Ministry of Health & Welfare, Republic of Korea (HI17C0597). |
|
Conflicts of interest: Dr Wei is listed on US patent no. 10,195,217 on the use of Cryosim-1 for the treatment of skin dysesthesias. Drs Jung, Kim, Selescu, Chung, Park, and Kim have no conflicts of interest to declare. |
|
IRB approval status: The study was approved by the Hallym University Kangnam Sacred Heart Hospital (record no. 2017-10-012-003). |
|
Reprints not available from the authors. |
Vol 84 - N° 3
P. 869-871 - mars 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?